Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Contamine-Sur-Arve – page 2

17 clinical trials in Contamine-Sur-Arve, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Contamine-Sur-Arve at a glance
17
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

17 trials in Contamine-Sur-Arve

Open in trial search
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Unicancer
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Binimetinib
  • Sponsor:Intergroupe Francophone De Cancerologie Thoracique
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Azathioprine
  • Sponsor:Centre Hospitalier Departemental Vendee
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Charcoal, Activated
  • Sponsor:Novartis Pharma AG
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Clinipace Global Limited

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Contamine-Sur-Arve

What the registry says about research in the country

01 Contamine-Sur-Arve
Neoplasms and Cancer Care
In Contamine-Sur-Arve, several trials focus on neoplasms, especially lung cancer, breast cancer, ovarian cancer, and colon cancer. These studies are aimed at improving survival, reducing recurrence, and helping doctors choose more effective treatment strategies. Testing new approaches for non-small cell lung cancer and small cell lung cancer Studying treatment options for HER2-positive, HR-positive, and high-risk breast cancer Evaluating better care for ovarian cancer and colon cancer Assessing therapies that may improve progression-free survival and disease-free survival This area reflects a strong interest in both advanced treatment and more precise cancer decision-making.
Respiratory Tract Diseases
Research in respiratory tract diseases centers on lung cancer and acute pneumonia, with trials exploring better ways to control disease and improve outcomes for older and high-risk patients. Evaluating treatment strategies for advanced lung cancer Studying adjuvant care after surgery for resected non-small cell lung cancer Testing supportive treatment for acute pneumonia in older adults The work in this field aims to refine both cancer therapy and infection management in respiratory care.
Bacterial Infections and Mycoses
Trials in bacterial infections are examining treatment options for staphylococcal prosthetic joint infection, with the goal of improving infection control while preserving joint function. Studying oral antibiotic options for prosthetic joint infection Supporting better management of staphylococcal infections Looking at treatment effectiveness in debridement and implant retention care This research focuses on practical infection treatment choices that may help patients avoid more invasive care.
Digestive System Diseases
Studies in digestive system diseases are centered on colon cancer and upper rectal cancer, with a clear focus on improving relapse prevention after surgery. Evaluating adjuvant treatment for colon adenocarcinoma Studying relapse-free survival after resection of stage III colon cancer Using new markers to guide therapy for colon cancer These trials aim to support more personalized follow-up care after curative surgery.
Nervous System Diseases
In the field of nervous system diseases, trials are focused on multiple sclerosis, comparing therapies designed to lower relapse frequency and improve long-term disease control. Assessing treatment effectiveness in relapsing multiple sclerosis Comparing approaches that may reduce confirmed relapses Exploring better long-term control of chronic neurological disease The goal is to identify options that provide steadier disease management for patients over time.
Analytical, Diagnostic and Therapeutic Techniques and Equipment
Research in diagnostic and therapeutic techniques includes studies using blood-based markers and other tools to guide treatment decisions in cancer and inflammatory disease. Using circulating tumor DNA to guide adjuvant care in colon cancer Exploring molecular response to help select therapy in metastatic breast cancer Investigating precision approaches in lung cancer and ovarian cancer These studies highlight a broader move toward more individualized diagnosis and treatment planning.
Inflammatory and Autoimmune Disease Research
Trials also address serious autoimmune conditions such as ANCA vasculitis and end-stage renal disease, with a focus on balancing disease control and treatment burden. Evaluating whether treatment can be safely reduced in ANCA vasculitis Studying outcomes in patients with end-stage renal disease Looking at long-term safety and survival-related outcomes This work seeks to support safer, more sustainable care for patients with complex chronic illness.
Other Clinical Research Areas
The local research portfolio in Contamine-Sur-Arve also includes studies in broader therapeutic areas, such as treatment optimization for older adults and evaluation of supportive care strategies. Improving care for older patients with breast cancer and lung cancer Assessing treatment strategies for high-risk patients across several diseases Exploring ways to improve survival and reduce relapse in difficult-to-treat conditions Together, these trials show a diverse clinical research environment with a strong emphasis on practical patient benefit.
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.